Tech Company M&A Transactions
ActivX Biosciences Acquisition
On 2/2/2005, ActivX Biosciences was purchased by Kwiry. Purchase price was estimated to be $21 million.
Transaction Overview
Company Name
Acquired By
Announced On
2/2/2005
Transaction Type
M&A
Amount
$21,000,000
M&A Terms
ActivX Biosciences, Inc., has announced the formal completion of its acquisition by Tokyo-based Kyorin Pharmaceutical Co., Ltd. (TSE: 4560). The acquisition agreement was signed on December 1, 2004 for an aggregate price of $21,000,000. With the completion of the transaction, ActivX survives as a wholly-owned subsidiary and will serve as Kyorin's drug discovery and development center in the U.S.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11025 North Torrey Pines Rd. 120
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Not Recorded
Overview
ActivX is an emerging biopharmaceutical company that discovers and develops highly selective, best in class, small molecule drugs for major unmet medical needs. ActivX uses its unique technology to identify target and off-target activities of drug candidates in the protein kinase and protease families with an initial focus on the areas of hematology, oncology, metabolic and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Kozarich
Browse more venture capital transactions:
Prev: 2/1/2005: Voxify venture capital transaction
Next: 2/3/2005: Dust Networks venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs